Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts

Aortic infections (AIs), including aortic graft infections (AGI) as well as mycotic aortic aneurysms (MAA), are rare. The aim of this study is to present our experience with xenogeneic aortic and aortoiliac reconstructions using the BioIntegral Surgical No-React® bovine pericardial graft.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Aortic Diseases Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario A Gemelli IRCCS

Rome, Italy

Location status: Recruiting

Location contact

Yamume Tshomba

CONTACT

[email protected]

‭+39 348 5456537‬

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aortic infection
Mycotic Aneurysm
Aortic Graft Infection

Exclusion criteria

Absence of signs of infection

Treatment and study plan

Aortic Surgery

Procedure

open surgical repair with resection of infected aortic segment, debridement of surrounding tissue and in situ graft replacement.

Primary outcomes

Early Mortality

Time frame: 30 days

Mortality 30 days after the procedure

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2025
Study completion: 2026
First posted: Mar 21, 2023
Registry last updated: Aug 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting